Evolent Health (US.EVH)
资本配置审计 · 期间： 2013 – 2026
核心指标
US.EVH · 同比： 2026 H1 vs 2025 H1
| 指标 | 数值 | 同比 |
|---|---|---|
| FCF Conversion | 228.7% | ↑ |
| ROE | -14.4% | → |
| Cash Conversion | - | → |
| D/E Ratio | 2.53 | ↓ |
| Gross Margin | 14.3% | ↓ |
US.EVH (Evolent Health) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 228.7% ↑ ROE -14.4% → Cash Conversion - → D/E Ratio 2.53 ↓ Gross Margin 14.3% ↓
核心指标
US.EVH (Evolent Health) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 228.7% ↑ROE -14.4% →Cash Conversion - →D/E Ratio 2.53 ↓Gross Margin 14.3% ↓免费公司
AppleMicrosoftAlphabet-CAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesMicron TechnologySanDiskSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies